PUT/FRESENIUS/15/0.1/20.06.25 Stock

Warrant

DE000GP76Z88

Market Closed - Bid/Ask 14:25:11 2024-07-01 EDT After market 15:58:55
0.021 EUR +5.00% Intraday chart for PUT/FRESENIUS/15/0.1/20.06.25 0.034 +61.90%
Current month-25.93%
1 month-31.03%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-01 0.021 +5.00%
24-06-28 0.02 +5.26%
24-06-27 0.019 0.00%
24-06-26 0.019 +5.56%
24-06-25 0.018 -10.00%

Real-time BOERSE MUENCHEN

Last update July 01, 2024 at 02:25 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying FRESENIUS SE & CO. KGAA
Issuer Goldman Sachs
WKN GP76Z8
ISINDE000GP76Z88
Date issued 2023-06-27
Strike 15
Maturity 2025-06-20 (354 Days)
Parity 10 : 1
Emission price 0.07
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.088
Lowest since issue 0.017
Delta-0.05x
Omega 4.155
Premium48.2x
Gearing83.24x
Moneyness 0.5300
Difference Strike -13.3
Difference Strike %-88.67%
Spread 0.03
Spread %61.22%
Theoretical value 0.0340
Implied Volatility 48.29 %
Total Loss Probability 87.91 %
Intrinsic value 0.000000
Present value 0.0340
Break even 14.66 €
Theta-0x
Vega0x
Rho-0x

Company Profile

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - hospital administration and engineering (64.3%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (35.7%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (72.4%), North America (12.3%), Asia/Pacific (7.3%), Latin America (6.4%) and Africa (1.6%).
Sector
-
More about the company

Ratings for Fresenius SE & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius SE & Co. KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
28.3 EUR
Average target price
37.26 EUR
Spread / Average Target
+31.65%
Consensus